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Diabetes mellitus is one of the most critical health conditions around the world, not only in terms of the
number of affected people, disability, and premature mortality, but also in regards to the health care costs
involved in controlling and treating its complications. Among the most constant ailments the diabetic patient
suffers is the diabetic foot, defined as any infection, ulceration, and/or necrosis of deep tissues associated
with neurological abnormalities and various degrees of peripheral vascular disease of the lower limbs.
Diabetic foot ulcerations have become a major and increasing public health concern and its associated
morbidities, impairment of the patients’ quality of life, and the implied costs for management have attracted
the attention of numerous health care providers. In this case report, the authors review a unique presentation
of a polymicrobial infection of a multi-drug resistant character species formed by oxacillin-resistant
Staphylococcus aureus, Acinetobacter baumannii and Acinetobacter lwoffii.
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A
ccording to the American Diabetes Association,
diabetes mellitus (DM) is defined as a group of
metabolic diseases characterized by hyperglyce-
mia resulting from defects in insulin secretion, insulin
action, or both. This condition of chronic hyperglycemia
is associated, after long periods, with injury and failure of
various organs, especially the eyes, kidneys, nerves, heart,
and blood vessels (1).
The diabetic population is currently increasing world-
wide, especially in developing countries like Brazil (2). In
1985, there were approximately 30 million adults suffer-
ing from diabetes in the world. In 1995, this figure
amounted to 135 million, while in 2002 the number of
diabetics was 173 million and is expected to reach a total
of 300 million in 2025. About two-thirds of diabetics live
in developing countries where the epidemic is most
intense with an increasing proportion in younger age
groups (2).
According to a study conducted between 1986 and
1988 in a population ranging from 30 to 69 years of age,
Brazil’s diabetes prevalence rate was 7.6% (3). A more
recent study conducted in Ribeira ˜o Preto, Sa ˜o Paulo,
showed a prevalence of 12.1% DM in the same age
group (4). It is estimated that in 2005, the number of
diabetics in Brazil amounted to an alarming figure of 8
million people (1). In the state of Rio Grande do Norte,
the prevalence of diabetes accounts for 9.4% and the
hospitalization rate due to complications from the disease
is equivalent to 2.7% (5).
It is well known that diabetic patients have a high
risk of developing complications including and not
limited to retinopathy, nephropathy, and neuropathy.
Among these complications, peripheral neuropathy is
directly associated with the onset of ulcers in the lower
limbs (6). Considering the various chronic complications
associated with diabetes, the diabetic foot is particularly
considered as the main cause of hospital admissions for a
significant portion of diabetic patients, and is also a
major cause of prolonged hospitalization among these
patients (6). World population data indicate that about
82,000 people have diabetes-related amputations of feet
and lower extremities each year (6). It is also estimated
that 1420% of diabetic patients with foot ulcers undergo
an amputation, while 85% of amputations are preceded
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siological mechanisms, and in diabetic patients, this is
mainly due to a complication of such a critical illness (8).
Neuropathy acts in a permissive way, and is present
in about 90% of patients with injury, demystifying
the perceived notion that the diabetic foot is mainly
a vascular complication. However, the incidence of
distal arterial lesions is higher in DM patients than in
people without diabetes (8). Generally, peripheral vascu-
lar disease (PVD) is not an independent risk factor for
these ulcers, but when associated with neuropathy it is a
major cause of non-traumatic amputations. Critical limb
ischemia hinders the healing process given the body’s
inability to provide nutrients and oxygen to the wound
bed. Infection is also more common by harming the
immune system and preventing antibiotic’s effectiveness
due to ischemia (8). The association between DM and
PVD can trigger the onset of a neuro-ischemic ulcer and
its prevalence is 34%. Ulcers caused by other factors not
associated with DM correspond to 1%. Each complica-
tion also increases the host’s susceptibility for developing
a different lesion (8).
The Wagner classification system is a widely accepted
stratification of diabetic foot ulcers, which, for the most
part, are infected with polymicrobial flora consisting of
aerobic, gram-negative, gram-positive, and anaerobic
bacteria (9). It is generally accepted that the majority of
mild to moderate infections are caused by gram-positive
bacteria, while severe infections and/or chronic diseases
are often polymicrobial, involving gram-negative and
anaerobic bacteria, which are responsible for 2060% of
the hospitalizations (10, 11).
The emergence and spread of microorganisms with
multi-drug resistance is currently considered as a major
public health concern, given its growing incidence in both
hospitals and communities. In a patient exposed to
antibiotics, resistant organisms may emerge by natural
selection through the expansion of subpopulations gen-
erated spontaneously (12). The multi-drug resistant
organisms of greater importance in the hospital environ-
ment include oxacillin-resistant Staphylococcus aureus,
vancomycin-resistant Enterococcus species (VRE), multi-
resistant Streptococcus pneumoniae, gram-negative organ-
isms, and multi-resistant gram negative bacteria including
Pseudomonas species, Acinetobacter species, Klebsiella
pneumoniae, Enterobacter species and other organisms
(13). Given this resistance’s panorama, it is necessary to
determine the bacteriological profile of admitted patients
in a hospital setting, and also determine the bacteriolo-
gical profile of hospitalized patients in order to reduce
the high rates of amputation and in-hospital mortality
rate in people with diabetes and foot ulcers (14). Patients
with diabetes have a 1225% lifetime risk of developing a
foot ulcer. Diabetic foot ulcers have increased the public
health care awareness and its associated morbidities,
patient’s quality life impairment, and the implied costs
for management have attracted the attention of numerous
health care providers (15).
Case report
An 86-year-old male presented to the emergency depart-
ment with a chief complaint of an ankle injury and a foot
non-healing ulcer sustained from a drill accident 2
months prior to his visit in our hospital. The patient
also related that he had diabetes for approximately 13
years without any treatment to control the disease.
During the initial consultation, the patient related no
use of any antibiotic therapy for his non-healing wound
to the right foot. The patient was admitted to the hospital
and further clinical and medical imaging revealed the
presence of a neuro-ischemic ulcer complicated with
infection and osteomyelitis (Fig. 1). The presence of
vascular compromise and osteomyelitis were diagnosed
by the vascular surgeon on call through the macroscopic
visualization of a large area of tissue necrosis, accom-
panied by abscess and radiological analysis respectively.
Initial laboratory analysis included a complete blood
count, accompanied by a fasting glucose level which was
requested shortly thereafter. The patient’s hemoglobin
was 8.8 mg/dL (reference value: 11.016.5 mg/dL),
hematocrit was 25.8% (reference value: 4254%) and
white blood cell count was 23.510
3/mm
3 (reference
value: 3.510.010
3/mm
3) with granulocyte percentage
equivalent to 85.6% (reference value: 43.076.0%). The
differential count showed a segmented neutrophil per-
centage of 80% (reference value: 5462%/2,7006,200/
mm
3), and 1% of eosinophils (reference value: 25%/
100500/mm
3). The random plasma glucose level corre-
sponded to 305 mg/dL (reference value: 7099 mg/dL).
Automated equipment (Abbott Cell-dyn1700 Diagnosis
and Bioplus BIO2000) were used to obtain the results of
the complete blood count and glucose levels, respectively.
At the time of the patient’s admission, a broad cover-
age of intravenous (IV) meropenem (500 mg/12 h) and IV
vancomycin (1 g/12 h) were initially administered empiri-
cally for 9 days in order to prevent any clinical and
systemic signs of sepsis. On the ninth day of hospitaliza-
tion, there was a progression of the infection with the
patient having systemic symptoms including increased
body temperature and diaphoresis. A consultation was
then made for wound debridement and obtaining of
wound specimens for bacterial cultures and antibiogram.
Before the clinical specimen was collected, the wound was
thoroughly cleaned and irrigated by using 0.85% sterile
sodium chloride solution, and subsequent drying it with
sterile gauze, thus preparing the site for physical debride-
ment. A sterile and disposable scalpel was then used for
this procedure, in order to remove all necrotic tissue that
enclosed the injury. After this stage, the wound was again
irrigated with a 0.85% sterile sodium chloride solution
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a sterile culture swab that was immediately placed in
Stuart transport medium (Difco Laboratories, Detroit,
MI, USA) and sent to the Laboratory Mycobacteria
(LABMIC), Brazil, for processing.
Upon arrival at LABMIC, the clinical specimen was
duly processed using protocols recommended by Murray
et al. (16). The specimen was then seeded in selective
MacConkey agar, blood agar, and liquid culture medium
brain heart infusion (BHI) broth (Difco Laboratories,
Detroit, MI, USA), followed by inoculation in conven-
tional atmosphere at 358C for 24 h. Biochemical tests
were then performed to identify bacteria at the species
level. Minimum inhibitory concentrations of vancomycin
and tigecycline were determined by E-test (AB bio-
disk, Solna, Sweden), while susceptibility to cefoxitin,
cefepime, ceftriaxone, chloramphenicol, ciprofloxacin,
clindamycin, erythromycin, oxacillin, gentamicin, imipe-
nem, rifampicin, tazobactam-piperacillin, tetracycline,
and trimethoprim/sulfamethoxazole was determined
using the disk diffusion test. All assays were performed
in accordance with clinical and laboratory standard in-
stitute guidelines (1719). Staphylococcus aureus (ATCC
25923) was included as control strains. In order to
establish a confirmation of the oxacillin-resistant strain,
a MuellerHinton agar supplemented with 4% sodium
chloride and oxacillin 6 mg/mL was used, followed by the
use of cefoxitin (30 mg) agar disk diffusion.
Final microbiological analysis revealed a polymicrobial
infection caused by multi-drug resistant organisms. The
identified organisms were Staphylococcus aureus resistant
to oxacillin, Acinetobacter baumannii, and Acinetobacter
lwoffii, all classified as multi-drug resistant if resistance
was found in 9 out of the 14 drugs tested. Accuracy was
verified by the reference laboratory using disk diffusion
on MuellerHinton agar (1719). Due to these results, the
patient was transferred to another hospital on the 25th
hospitalization day, with the recommendation of lower
extremity amputation.
Discussion
According to Carvalho et al. (20), some patients with
type 2 diabetes can remain for 10 years or even longer
with the disease before the diagnosis can be made by the
usual onset’s symptoms. This fact explains many cases
where the first manifestation is the appearance of a
chronic complication. In this case study, the duration of
diabetes reported by the patient was approximately 13
years. Another aspect that should be taken into con-
sideration was the patient’s denial and lack of knowledge
regarding his disease and the importance of proper foot
care. Knowing that the existence of an ulcer could be the
start of an infection in the diabetic foot, the need to
classify it according to its severity was made necessary.
The Wagner’s classification which was chosen in this case
study was classified as 5, characterized by the presence of
the foot’s extensive gangrene, with necrotic tissue and soft
tissue infection. The diabetic foot international consensus
(21) recommends the clinical specimen collection by
aspiration or biopsy of deep tissues. In this case study,
we used the procedures recommended by Johnson et al.
(22) and Sapico et al. (23). According to Wheat et al. (24),
who evaluated these procedures, the culture swab or
curettage collection provides the best results with regard
to the isolation of the greater number of bacteria when
compared to the collection made by suction, and when
the lesions are superficial or deep, with cellulitis but no
abscess (22).
The bacterial species isolated in this study were
oxacillin-resistant Staphylococcus aureus, Acinetobacter
baumannii, and Acinetobacter lwoffii, all with multi-drug
resistance standard phenotype. Oxacillin-resistant Sta-
phylococcus aureus strains represent a chronic problem in
Latin American hospitals. Data from the SENTRY
Fig. 1. Eighty-six years old diabetic patient with an infected neuro-ischemic ulceration and osteomyelitis.
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strains isolated in hospitals are resistant to oxacillin (23).
Carvalho et al., upon analyzing the resistance profiles of
isolated Staphylococcus aureus strains, showed a profile
of 11.5% (20). In addition, the patients had all under-
gone hospitalization once or more in the last 6 months,
and some were taking antibiotics at the time of collection.
Until the late 1970s, there was little evidence of the
spread of oxacillin-resistant Staphylococcus aureus strains
in the general population. However, since the 1980s,
several reports of oxacillin-resistant Staphylococcus aur-
eus infection in patients who had not been hospitalized
nor had contact with staff working in hospitals were
published (20).
It has been shown that the carrier status of oxacillin-
resistant Staphylococcus aureus persists in some patients
for several years, thus, ensuring the spread of these
strains, since these patients return to the general popula-
tion. In addition, there appears to be evidence of
oxacillin-resistant Staphylococcus aureus spread among
local populations and outside the risk groups. Further
studies are required to determine the state of dissemina-
tion of these strains in the community (24). An important
fact about our case report is that the collection of the
specimen for culture was only performed on the ninth day
of hospitalization and although the patient had reported
not having been admitted in the previous 6 months, the
colonization could have occurred in the same hospital.
This case report also identified two species of Acine-
tobacter’s genus (Acinetobacter baumannii and Acineto-
bacter lwoffii), both showing the phenotypic pattern of
resistance to all classes tested according to the recom-
mendations of the clinical and laboratory standards
institute (non-fermenting) for this bacterial genus. The
Acinetobacter lwoffii is generally commensal and is
present in normal skin microbiota in approximately
25% of healthy individuals (25). However, Acinetobacter
baumannii is the genus’species most often associated with
nosocomial infections and is rarely found in human skin
microbiota (26). The pathogenic potential of these
bacterial species is due to its various virulence factors
that allow their survival in the hospital environment as
well as the ability to cause disease, particularly in
debilitated patients (27).
Bacterial resistance is an issue that is becoming
increasingly common in diabetic foot infections. A
number of risk factors related to antibiotic resistance
have been shown in some studies. This includes previous
antibiotic therapy and its duration, frequency of hospi-
talization for the same wound, length of hospitalization
stay, and the presence of osteomyelitis (28). In our case
report, the patient reported of not having used antibiotics
prior to his injury as well as not having been hospitalized
in the previous 6 months. However, at the time of his
hospitalization, he received empirical treatment with
broad-spectrum antibiotics. Therefore, it could be sug-
gested that the natural selection imposed by antibiotics
led to the elimination of susceptible bacterial species
(vancomycin and meropenem), leaving only the resistant
strains in the damaged tissue (29).
The biofilm’s role formation on common chronic
wounds or wounds that are difficult to heal with
treatment has gained increasing attention in the clinical
setting, due to its implication in resistance to treatment
and presence of infection. Biofilms represent commu-
nities of microbial cells attached both to a surface and to
each other and embedded in a matrix and extracellular
polymeric substances. These polymeric substances are
produced by the microorganisms in order to increase
their chance of survival in a given environment (30, 31).
There is strong evidence that different bacterial species in
these ecosystems join together, amplifying the possible
exchange of genetic information. The proliferation of
these organisms occurs more slowly, therefore hindering
the action of the antimicrobial agent that acts mainly
when the bacterial cells are in the process of division.
Furthermore, these bacterial cells are much more pro-
tected from antibiotics, which have limited access to
niches where they are, and from the host response, which
in the diabetic patient is already weakened due to
peripheral vascular disease and the already installed
setting of immunosuppression that is characterized with
diabetes (32, 33).
The existence of biofilms greatly complicates the
clinical use of antimicrobials, favoring the emergence of
resistant bacteria. Multi-drug resistant bacteria are
associated with treatment failure and increased morbidity
and mortality rates. In the absence of a microbiology
laboratory at the center studied, the choice of the
antimicrobial agent in the treatment of a diabetic patient
with an infected foot ulcer was carried out empirically
(34). The need for an etiological diagnosis and treatment
follow-up of these patients was noted. Study on anti-
microbial resistance in developing countries reported the
discovery of high percentages of isolates resistant to
antimicrobials and warned against the absence or lack of
microbiology laboratories in those countries (23). The
implementation of these labs would lead to treatments
based on isolating the agent and on determining the
sensitivity profile in regards to antimicrobial agents.
Empirical treatments could jeopardize the implementa-
tion of treatment strategies, seeing as the resistance varies
from region to region, leading to insufficient treatment of
patients in these countries, as well as to increased costs
and morbidity and mortality rates.
Conclusion
Unfortunately, multi-drug resistant organisms have be-
come increasingly common, making empirical therapy
decisions more difficult (35). In many cases, empirical
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have no microbiology laboratories and limited resources.
This case report emphasized the need of health care
centers and providers for improvements on microbiolo-
gical laboratories in a hospital or medical center. In
addition, periodic antibiotic resistance surveys could also
help all health care providers as well as the local
population on the best treatment strategies.
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